Stocktoria
Nkarta, Inc. NKTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-07-10
Chart by TradingView
1/9
Piotroski F — financial health
0.54
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $0 | $0 | — | — | $0 |
| Operating income | -$122.0M | -$128.2M | -$131.7M | -$119.0M | -$86.4M |
| Net income | -$104.1M | -$108.8M | -$117.5M | -$113.8M | -$86.1M |
| Operating cash flow | -$88.7M | -$99.7M | -$86.2M | -$57.0M | -$67.9M |
| Free cash flow | -$89.9M | -$104.1M | -$114.3M | -$104.1M | -$73.0M |
| Total assets | $404.2M | $501.2M | $378.9M | $472.9M | $273.9M |
| Total liabilities | $91.9M | $93.2M | $105.6M | $100.7M | $22.9M |
| Shareholders' equity | $312.3M | $408.0M | $273.3M | $372.2M | $251.0M |
| Ratios | |||||
| Return on assets | -25.8% | -21.7% | -31.0% | -24.1% | -31.4% |
| Return on equity | -33.3% | -26.7% | -43.0% | -30.6% | -34.3% |
| Current ratio | 12.69 | 14.45 | 10.85 | 16.36 | 18.99 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 1,732,372 | $3.7M |
| Point72 Asset Management, L.P. | 60,348 | $127,334 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 0.54 (distress)
- Working capital / assets 0.644
- Retained earnings / assets -1.604
- EBIT / assets -0.302
- Equity / liabilities 3.399
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001787400 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.